使用微阵列多态性位点相对定量法测量胎儿分数的准确性与可重复性
本研究利用Harmony®产前检测中整合的多态性测定,在47 512例连续孕妇血浆样本中比较基于多态性测定的胎儿分数与Y序列定量的结果,并在734例中评估同一患者样本第一管与第二管测量的可重复性,另在13 988例样本中计算信息性位点比例。结果显示多态性测定与Y染色体序列定量的胎儿分数强相关(r=0.97),两管间测量高度可重复(r=0.98),信息性位点比例与测定设计预测一致。结论认为基于微阵列多态性位点相对定量的方法用于胎儿分数估计准确且可重复,在全球人群中信息量相当。
要点
- 多态性测定与Y染色体序列定量的胎儿分数强相关(r=0.97)。
- 同一患者样本第一管与第二管测量的胎儿分数高度可重复(r=0.98)。
- 临床系列中信息性位点比例与测定设计预测一致。
核心结论
- 基于微阵列多态性位点相对定量的方法用于胎儿分数估计准确且可重复,在全球人群中信息量相当。
- 本研究为保障胎儿分数测量的可靠性和准确性提供了有用的基准。
研究设计与样本
- 使用定制微阵列与选定区域数字分析(DANSR)测定,覆盖13、18、21、X和Y染色体上的非多态性靶点及用于胎儿分数评估的多态性靶点。
- 在47 512例连续孕妇血浆样本中,将基于多态性测定的胎儿分数测量与Y序列定量进行比较。
- 在734例中评估同一患者样本第一管与第二管测量的可重复性。
- 在13 988例样本中计算信息性位点比例。
主要发现
- 基于多态性测定与基于Y染色体序列定量确定的胎儿分数之间强相关(r=0.97)。
- 第一管与第二管之间的胎儿分数测量高度可重复(r=0.98)。
- 临床系列中观察到的信息性位点比例与基于测定设计的预测一致。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Various methods of fetal-fraction measurement have been employed in conjunction with different approaches to cell-free DNA testing for fetal aneuploidy. In this study, we determined the accuracy and reproducibility of fetal-fraction measurement using polymorphic assays that are incorporated into the test design as part of the Harmony® prenatal test and evaluated whether the single nucleotide polymorphisms selected for and used in these assays can be applied broadly to all patient populations. METHODS: Clinical maternal plasma samples were assayed using a custom microarray with Digital ANalysis of Selected Regions (DANSR) assays designed to cover non-polymorphic targets on chromosomes of interest for aneuploidy assessment (13, 18, 21, X and Y) and polymorphic targets for fetal-fraction assessment. In a consecutive series of 47 512 maternal plasma samples, fetal-fraction measurements based on polymorphic assays were compared with those from Y-sequence quantitation. Reproducibility was examined between first- and second-tube measurements for the same patient sample in 734 cases. The fraction of informative loci was calculated for 13 988 samples. RESULTS: There was a strong correlation between fetal fractions determined using the polymorphic assays and using Y-chromosome sequence quantitation (r = 0.97). Fetal-fraction measurement between the first and second tubes was highly reproducible (r = 0.98). The fraction of informative loci observed in a clinical series was consistent with predictions based on assay design. CONCLUSIONS: The method based on relative quantitation at polymorphic loci on a microarray is accurate and reproducible for fetal-fraction estimation and is equally informative across global populations. This study provides a useful benchmark for ensuring the reliability and accuracy of fetal-fraction measurement. © 2018 Roche Sequencing Solutions. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Schmid M, White K, Stokowski R, et al. Accuracy and reproducibility of fetal-fraction measurement using relative quantitation at polymorphic loci with microarray. Ultrasound Obstet Gynecol. 2018. PMID: 29484786. doi:10.1002/uog.19036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。